CHARACTERIZATION OF THE PEMPHIGUS FOLIACEUS ANTIGEN

落叶型天疱疮抗原的特征

基本信息

  • 批准号:
    3160272
  • 负责人:
  • 金额:
    $ 14.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-09-20 至 1994-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the applicant's abstract): Pemphigus foliaceus (PF) is an autoimmune skin disease that has been recently characterized as a simple model for other organ-specific, antibody-mediated autoimmune diseases. An experimental passive transfer animal model is available for this disease and the resulting lesions are rapidly produced (less than 24h) and easily monitored. The investigators have recently shown that monovalent Fab fragments of the autoantibodies (AAb) are pathogenic and produce the disease faster and more efficiently than the intact AAb proving the primary lesion is the direct result of blocking the function of the antigen (Ag) by the AAb. The PF Ag is thought to be a 160 kD desmosomal core protein, desmoglein I (DG-1). The investigators have recently reported the presence of an insoluble trypsin resistant Ag in the cornified cell envelope fraction of human epidermis. An immunoreactive soluble 50 KD papain fragment of this PF Ag (pf-PF) could be released into solution and specifically immunoprecipitated by PF sera. Also, the investigators obtained another 45 KD fragment (tf-PF) by trypsin treatment of viable epidermal cells, and the investigators could partially purify it by concanavalin A affinity chromatography and immunoprecipitation. These findings suggested the presence of three different pools of PF Ag: a soluble pool from which PF Ag was initially immunoprecipitated by other investigators, a cell-surface trypsin-sensitive pool, and a cornified cell envelope-associated trypsin resistant pool. The aims of this grant proposal are to purify these fragments, study their relation to DG-I or the native PF Ag, determine differences between these pools of PF Ag, and study the epitopes of the Ag that are detected by PF autoantibodies and are responsible for the pathology in this disease. DG-I, pf-PF, and tf-PF will be purified and characterized chemically and immunologically. For the chemical characterization, amino acid and carbohydrate analysis, peptide mapping, and partial sequencing will be done. For immunological studies, polyclonal and monoclonal antibodies will be raised and their immunochemical and possible pathogenic potentials studied. Monoclonal antibodies will be used for epitope mapping by competitive studies with the PF AAb. Antibodies will be also used for preparation of pure PF Ag or its proteolytic fragments for further characterization and to study their potential pathogenic and therapeutic effects. To assure sufficient supply of PF Ag and to help in the characterization of the immunoreactive epitopes, cDNA will be purified from a keratinocyte cDNA library, fusion protein will be tested for immunoreactivity, and probes will be made to search for PF Ag mRNA and full length PF cDNA. Finally, immunoreactivity of the native PF antigen or its fragments will be compared to that of the antigen expressed in vitro from full or partial length cDNAs. The applicants believe that these studies will likely provide important basic information about the Ag-AAb interactions that initiate the pathology in this autoimmune disease. This information should pave the way for consideration of specific therapeutic intervention in PF as a model for other antibody-mediated autoimmune disorders, and will aid significantly in understanding differentiation and cell adhesion in the epidermis.
描述(改编自申请人摘要):天疱疮叶状

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GRANT J ANHALT其他文献

GRANT J ANHALT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GRANT J ANHALT', 18)}}的其他基金

AN OPEN-LABEL, DOSE-ESCALATION, PHASE I STUDY TO ASSESS PI-0824 SAFETY
评估 PI-0824 安全性的开放标签、剂量递增、I 期研究
  • 批准号:
    7200751
  • 财政年份:
    2005
  • 资助金额:
    $ 14.64万
  • 项目类别:
An Open-Label, Dose-Escalation, Phase I Study to Assess PI-0824 Safety
评估 PI-0824 安全性的开放标签、剂量递增、第一阶段研究
  • 批准号:
    7044705
  • 财政年份:
    2003
  • 资助金额:
    $ 14.64万
  • 项目类别:
PATHOPHYSIOLOGY OF PEMPHIGUS IN VIVO
天疱疮体内病理生理学
  • 批准号:
    6534284
  • 财政年份:
    2000
  • 资助金额:
    $ 14.64万
  • 项目类别:
PATHOPHYSIOLOGY OF PEMPHIGUS IN VIVO
天疱疮体内病理生理学
  • 批准号:
    6374608
  • 财政年份:
    2000
  • 资助金额:
    $ 14.64万
  • 项目类别:
PATHOPHYSIOLOGY OF PEMPHIGUS IN VIVO
天疱疮体内病理生理学
  • 批准号:
    6191052
  • 财政年份:
    2000
  • 资助金额:
    $ 14.64万
  • 项目类别:
CHARACTERIZATION OF THE PEMPHIGUS FOLIACEUS ANTIGEN
落叶型天疱疮抗原的特征
  • 批准号:
    3160274
  • 财政年份:
    1991
  • 资助金额:
    $ 14.64万
  • 项目类别:
CHARACTERIZATION OF THE PEMPHIGUS FOLIACEUS ANTIGEN
落叶型天疱疮抗原的特征
  • 批准号:
    3160273
  • 财政年份:
    1991
  • 资助金额:
    $ 14.64万
  • 项目类别:
PATHOGENICITY OF PEMPHIGUS AND PEMPHIGOID ANTIBODIES
天疱疮和类天疱疮抗体的致病性
  • 批准号:
    3071305
  • 财政年份:
    1987
  • 资助金额:
    $ 14.64万
  • 项目类别:
PATHOGENICITY OF PEMPHIGUS AND PEMPHIGOID ANTIBODIES
天疱疮和类天疱疮抗体的致病性
  • 批准号:
    3071307
  • 财政年份:
    1987
  • 资助金额:
    $ 14.64万
  • 项目类别:
PATHOGENICITY OF PEMPHIGUS AND PEMPHIGOID ANTIBODIES
天疱疮和类天疱疮抗体的致病性
  • 批准号:
    3071308
  • 财政年份:
    1987
  • 资助金额:
    $ 14.64万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 14.64万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 14.64万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 14.64万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 14.64万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了